// AST – IMS - [DMinute_ROS]

Tenneco (TEN) to pay $0.25 on Dec 21, 2018; Halo Technology Holdings Has 0.95 Sentiment

Tenneco Inc. (NYSE:TEN) Logo

Halo Technology Holdings Inc (HALO) investors sentiment decreased to 0.95 in Q2 2018. It’s down -0.56, from 1.51 in 2018Q1. The ratio dropped, as 80 funds increased and started new positions, while 84 sold and reduced their stock positions in Halo Technology Holdings Inc. The funds in our database now hold: 118.72 million shares, down from 119.54 million shares in 2018Q1. Also, the number of funds holding Halo Technology Holdings Inc in top ten positions decreased from 4 to 2 for a decrease of 2. Sold All: 25 Reduced: 59 Increased: 55 New Position: 25.

Tenneco Inc (NYSE:TEN) is expected to pay $0.25 on Dec 21, 2018. (NYSE:TEN) shareholders before Dec 3, 2018 will receive the $0.25 dividend. Tenneco Inc’s current price of $34.10 translates into 0.73% yield. Tenneco Inc’s dividend has Dec 4, 2018 as record date. Oct 10, 2018 is the announcement. The stock increased 4.06% or $1.33 during the last trading session, reaching $34.1. About 633,866 shares traded or 3.21% up from the average. Tenneco Inc. (NYSE:TEN) has declined 24.42% since November 27, 2017 and is downtrending. It has underperformed by 40.04% the S&P500. Some Historical TEN News: 10/04/2018 – Tenneco Buy of Federal Mogul To Be Funded Through Cash, Tenneco Equity and Assumption of Debt; 11/04/2018 – Industry Week: Icahn Sells Federal-Mogul to Tenneco for $5.4 Billion; 27/04/2018 – Tenneco Inc. 1Q Net Profit Rises 1.7%; Backs 2018 Revenue Outlook; 27/04/2018 – Tenneco Expects Constant Currency Rev Growth of 8% in 2Q; 10/04/2018 – Crain’s Detroit Biz: BREAKING: Tenneco to acquire Federal-Mogul in $5.4 billion deal; 21/04/2018 – DJ Tenneco Inc, Inst Holders, 1Q 2018 (TEN); 27/04/2018 – TENNECO 1Q ADJ EPS $1.58; 18/05/2018 – TENNECO NAMES JASON HOLLAR CFO; 27/04/2018 – Tenneco Expects 5% Organic Rev Growth for 2018; 10/04/2018 – TENNECO TO CREATE TWO INDEPENDENT, PUBLIC COS. WITH PURCHASE OF

Investors sentiment decreased to 0.89 in Q2 2018. Its down 0.41, from 1.3 in 2018Q1. It dived, as 43 investors sold Tenneco Inc. shares while 79 reduced holdings. 28 funds opened positions while 81 raised stakes. 44.74 million shares or 4.27% less from 46.74 million shares in 2018Q1 were reported. Towle And reported 533,750 shares or 2.26% of all its holdings. Susquehanna Grp Limited Liability Partnership has 34,028 shares. Archford Cap Strategies Ltd Liability has invested 0% in Tenneco Inc. (NYSE:TEN). D E Shaw & Inc holds 0.01% or 242,337 shares in its portfolio. Valley Natl Advisers accumulated 8 shares or 0% of the stock. 30,100 were reported by Virginia Retirement Systems Et Al. 109,002 were reported by Panagora Asset Management. Lyrical Asset Limited Partnership holds 2.55M shares. Sageworth Com stated it has 0% of its portfolio in Tenneco Inc. (NYSE:TEN). Salem Counselors Inc holds 7 shares. Bartlett & Ltd Liability Corporation has 0% invested in Tenneco Inc. (NYSE:TEN) for 400 shares. Hillcrest Asset, Texas-based fund reported 159,117 shares. Hgk Asset accumulated 11,590 shares or 0.09% of the stock. Monroe Retail Bank And Mi reported 187 shares or 0% of all its holdings. Keybank Association Oh has 10,860 shares.

Among 2 analysts covering Tenneco (NYSE:TEN), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Tenneco has $41 highest and $30 lowest target. $35.50’s average target is 4.11% above currents $34.1 stock price. Tenneco had 3 analyst reports since August 13, 2018 according to SRatingsIntel. Morgan Stanley maintained Tenneco Inc. (NYSE:TEN) rating on Monday, August 13. Morgan Stanley has “Equal-Weight” rating and $40 target. The stock has “Underweight” rating by Morgan Stanley on Wednesday, November 14. As per Monday, October 29, the company rating was maintained by Wells Fargo.

More notable recent Tenneco Inc. (NYSE:TEN) news were published by: Globenewswire.com which released: “TEN, Ltd Announces 24th Long-Term Charter Year-to-Date – GlobeNewswire” on November 26, 2018, also Globenewswire.com with their article: “TEN Ltd. Declares Dividend on its Series D and Series E Cumulative Perpetual Preferred Shares – GlobeNewswire” published on November 06, 2018, Seekingalpha.com published: “Spotify: Undervalued And With A $1-Billion Buyback Program – Seeking Alpha” on November 27, 2018. More interesting news about Tenneco Inc. (NYSE:TEN) were released by: Gurufocus.com and their article: “Carl Icahn: Not Slowing Down at 82 – GuruFocus.com” published on November 19, 2018 as well as Seekingalpha.com‘s news article titled: “Auto suppliers PTs cut at Morgan Stanley – Seeking Alpha” with publication date: November 14, 2018.

Tenneco Inc. designs, manufactures, and distributes clean air and ride performance products and systems for light vehicle, commercial truck, off-highway, and other vehicle applications worldwide. The company has market cap of $2.76 billion. The firm offers various vehicle emission control products and systems, including catalytic converters and diesel oxidation catalysts, diesel particulate filters, burner systems, lean nitrogen oxide traps, hydrocarbon vaporizers and injectors, selective catalytic reduction (SCR)systems, SCR-coated diesel particulate filters (SDPF) systems, urea dosing systems, four-way catalysts, alternative NOx reduction technologies, mufflers and resonators, fabricated exhaust manifolds, pipes, hydroformed assemblies, elastomeric hangers and isolators, and after treatment control units. It has a 7.61 P/E ratio. It also provides ride performance products and systems, such as shock absorbers; struts; vibration control components; kinetic suspension technology systems, dual-mode suspension solutions, semi-active and active suspension systems, and kinetic H2/CVSA continuously variable semi active suspension systems; and other ride performance products comprising load assist products, springs, steering stabilizers, adjustable suspension systems, suspension kits, and modular assemblies.

Third Security Llc holds 23.42% of its portfolio in Halozyme Therapeutics, Inc. for 17.29 million shares. Bb Biotech Ag owns 8.25 million shares or 4.02% of their US portfolio. Moreover, Sterling Global Strategies Llc has 2.39% invested in the company for 22,000 shares. The Minnesota-based First Light Asset Management Llc has invested 2.34% in the stock. Snyder Capital Management L P, a California-based fund reported 2.38 million shares.

More notable recent Halozyme Therapeutics, Inc. (NASDAQ:HALO) news were published by: Streetinsider.com which released: “After-Hours Movers 11/26: (MXIM) (PCG) (FANG) Higher; (GSM) (HALO) (GTHX) Lower (more…) – StreetInsider.com” on November 26, 2018, also Nasdaq.com with their article: “Halo Labs: Improving Investor Reach, Transparency, and Liquidity — CFN Media – Nasdaq” published on November 21, 2018, Nasdaq.com published: “Report: Exploring Fundamental Drivers Behind Entergy, BLACKLINE INC, HollyFrontier, Hill-Rom, Apache, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments – Nasdaq” on November 08, 2018. More interesting news about Halozyme Therapeutics, Inc. (NASDAQ:HALO) were released by: Benzinga.com and their article: “Halozyme Therapeutics, Inc. (NASDAQ:HALO) – A Preview Of Halozyme Therapeutics Q3 Earnings – Benzinga” published on November 06, 2018 as well as Seekingalpha.com‘s news article titled: “Halozyme Q3 revenues $25.6M, guidance raised – Seeking Alpha” with publication date: November 06, 2018.

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes and other drug candidates in the United States, Switzerland, and internationally. The company has market cap of $2.40 billion. The companyÂ’s human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. It has a 54.97 P/E ratio. The Company’s products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids.

The stock increased 3.98% or $0.64 during the last trading session, reaching $16.71. About 625,903 shares traded. Halozyme Therapeutics, Inc. (HALO) has risen 32.24% since November 27, 2017 and is uptrending. It has outperformed by 16.62% the S&P500. Some Historical HALO News: 10/05/2018 – HALOZYME 1Q REV. $30.9M, EST. $31.8M; 10/04/2018 – Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination With Keytruda and anti-CD73 at Intl Oncolytic Virus Conference 2018; 29/05/2018 – Phase lll lMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to; 13/03/2018 – FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer; 30/04/2018 – FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting; 22/03/2018 – HEALTH CANADA APPROVES RITUXAN® SUBCUTANEOUS FORMULATION FOR CANADIANS WITH CHRONIC LYMPHOCYTIC LEUKEMIA; 10/05/2018 – HALOZYME REITERATES 2018 FINL GUIDANCE; 17/05/2018 – Quest Diagnostics adds Helen Torley to Board of Directors; 09/04/2018 – MERCK & CO INC – SAFETY PROFILE OF KEYTRUDA IN PHASE 3 TRIAL WAS CONSISTENT

Tenneco Inc. (NYSE:TEN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.